Fetal Cell Analysis From Maternal Blood
NCT05671744 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1500
Last updated 2023-01-05
Summary
The aim of this clinical study is the evaluation of clinical performance of a cell-based non-invasive test technology for fetal aneuploidies and segmental imbalances detection in a high-risk pregnancies population.
Conditions
- Prenatal Screening
- Pregnancy Related
- Genetic Disease
Interventions
- OTHER
-
Cell-based non-invasive prenatal testing
Blood sampling
Sponsors & Collaborators
-
Menarini Biomarkers Singapore
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-22
- Primary Completion
- 2023-09-30
- Completion
- 2023-09-30
Countries
- Italy
Study Locations
More Related Trials
-
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
NCT04285814 ·Status: COMPLETED
-
Development of a Non-invasive Prenatal Test
NCT01451684 ·Status: COMPLETED
-
Cell-based Non-invasive Prenatal Testing as an Alternative to Invasive Chorionic Villus Sampling
NCT05453474 ·Status: COMPLETED ·Phase: NA
-
PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood
NCT03831256 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies
NCT01052688 ·Status: COMPLETED
-
Cell Based Non Invasive Prenatal Testing as an Alternative to Chorionic Villus Sampling Following Preimplantation Genetic Testing
NCT04584047 ·Status: COMPLETED ·Phase: NA
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Validation of a Test for Fetal Malformations
NCT02965287 ·Status: COMPLETED
-
NIPD of CFTC by WGA Coupled to Mini-exome Sequencing
NCT03743948 ·Status: UNKNOWN ·Phase: NA
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
NCT01555346 ·Status: COMPLETED
-
Efficacy Evaluation of Using Finger Stick Peripheral Blood for Point of Care Pregnancy Testing
NCT06747598 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy
NCT02317965 ·Status: UNKNOWN
-
Cell-Based Noninvasive Prenatal Testing
NCT05245266 ·Status: UNKNOWN ·Phase: NA
-
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
NCT06147414 ·Status: RECRUITING
-
Prenatal Test for Fetal Aneuploidy Detection
NCT01256606 ·Status: COMPLETED
-
High Risk Multiple Gestation Study
NCT02278874 ·Status: COMPLETED
-
Clinical Performance of NIPT in Multiple Gestation Pregnancies
NCT04488393 ·Status: COMPLETED
-
First Trimester Risk Assessment Based on Ultrasound and Cell-free DNA vs Combined Screening
NCT04077060 ·Status: COMPLETED ·Phase: NA
-
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00971334 ·Status: COMPLETED
-
Expanded NIPT for Pregnancy Complications
NCT04311749 ·Status: COMPLETED
-
Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy
NCT02982356 ·Status: UNKNOWN ·Phase: NA
-
National Prevalence and Impact of Noninvasive Prenatal Testing
NCT02284399 ·Status: COMPLETED
-
Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells
NCT06523543 ·Status: RECRUITING
-
Non Ivasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis
NCT02130648 ·Status: UNKNOWN